Next Article in Journal
Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796
Next Article in Special Issue
Impact of Relative Biologic Effectiveness for Proton Therapy for Head and Neck and Skull-Base Tumors: A Technical and Clinical Review
Previous Article in Journal
Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study
Previous Article in Special Issue
Adaptive Radiotherapy: Next-Generation Radiotherapy
 
 
Article

Article Versions Notes

Cancers 2024, 16(6), 1210; https://doi.org/10.3390/cancers16061210
Action Date Notes Link
article pdf uploaded. 19 March 2024 17:21 CET Version of Record https://www.mdpi.com/2072-6694/16/6/1210/pdf-vor
article supplementary file uploaded. 19 March 2024 17:21 CET - https://www.mdpi.com/2072-6694/16/6/1210#supplementary
article xml file uploaded 20 March 2024 07:43 CET Original file -
article xml uploaded. 20 March 2024 07:43 CET Update -
article pdf uploaded. 20 March 2024 07:43 CET Updated version of record https://www.mdpi.com/2072-6694/16/6/1210/pdf-vor
article html file updated 20 March 2024 07:46 CET Original file -
article pdf uploaded. 2 April 2024 09:24 CEST Minor correction https://www.mdpi.com/2072-6694/16/6/1210/pdf
article xml uploaded. 2 April 2024 09:24 CEST Minor correction https://www.mdpi.com/2072-6694/16/6/1210/xml
article html file updated 2 April 2024 09:25 CEST Update https://www.mdpi.com/2072-6694/16/6/1210/html
Back to TopTop